SG
Sharper & Granite’s iShares Biotechnology ETF IBB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $982K | Buy |
7,580
+1,410
| +23% | +$183K | 0.37% | 68 |
|
|
2025
Q1 | $789K | Sell |
6,170
-80
| -1% | -$10.2K | 0.33% | 66 |
|
|
2024
Q4 | $826K | Buy |
6,250
+170
| +3% | +$22.5K | 0.36% | 68 |
|
|
2024
Q3 | $885K | Buy |
6,080
+365
| +6% | +$53.1K | 0.4% | 63 |
|
|
2024
Q2 | $784K | Buy |
5,715
+115
| +2% | +$15.8K | 0.37% | 66 |
|
|
2024
Q1 | $742K | Sell |
5,600
-175
| -3% | -$23.2K | 0.36% | 67 |
|
|
2023
Q4 | $785K | Buy |
5,775
+155
| +3% | +$21.1K | 0.41% | 65 |
|
|
2023
Q3 | $687K | Buy |
5,620
+185
| +3% | +$22.6K | 0.4% | 66 |
|
|
2023
Q2 | $690K | Buy |
5,435
+95
| +2% | +$12.1K | 0.4% | 65 |
|
|
2023
Q1 | $690K | Sell |
5,340
-85
| -2% | -$11K | 0.41% | 65 |
|
|
2022
Q4 | $712K | Buy |
+5,425
| New | +$712K | 0.47% | 61 |
|